Health food, the blue-hat category, has required pre-market registration or filing since the dual-track system under the ...

T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been ...

MPCi-led financing will advance Convergen’s proprietary TrimTAC degrader platform and accelerate its lead programme towards ...

It was approved by the Health Sciences Authority for the treatments of stage 1 or 2 hATTR-PN (October 2024)[3], and wild-type ...

Further the resilience of the supply chain for important medicines by donating 25 kg of tacrolimus active pharmaceutical ...

Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of ...

The pharmaceutical services major increases its interim shareholder payout from RMB 1.03 billion in 2025, while continuing to ...

SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress ...

Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational ...

Oliver Healthcare Packaging brings specialised sterile barrier and packaging solutions for medical devices, diagnostics, ...

- Topline data from the AURORA Phase III clinical program are expected in the third quarter of 2028, with a U.S. Food and ...

DUALITYBIO Inc. announced that it has entered into a collaboration and license agreement with Genentech, a member of the ...